➡️ Get instant news updates on Whatsapp. Click here to join our Whatsapp Group. |
Asston Pharmaceuticals has released IPO and all details of IPO such as last date to apply, price, prospectus PDF and all other details are given below.
Asston Pharmaceuticals IPO Details
IPO Open Date: | July 9, 2025 |
IPO Close Date: | July 11, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹115 to ₹123 Per Share |
Issue Size: | Approx ₹27.56 Crores |
Fresh Issue: | Approx ₹27.56 Crores |
Issue Type: | Book Build Issue |
IPO Listing: | BSE SME |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
Download Prospectus PDF | Click Here |
Schedule and Dates of Asston Pharmaceuticals
Issue open date | 09 Jul 2025 |
Issue close date | 11 Jul 2025 |
UPI mandate deadline | 11 Jul 2025 (5 PM) |
Allotment finalization | 14 Jul 2025 |
Refund initiation | 15 Jul 2025 |
Share credit | 15 Jul 2025 |
Listing date | 16 Jul 2025 |
Mandate end date | 26 Jul 2025 |
Lock-in end date for anchor investors (50%) | 13 Aug 2025 |
Lock-in end date for anchor investors (remaining) | 12 Oct 2025 |
About Asston Pharmaceuticals
Asston Pharmaceuticals makes medicines and health supplements for customers in India and Africa under its own brand name “Asston.” The company’s manufacturing unit is located in Ambernath, Maharashtra, where it produces tablets, capsules, syrups, creams, and powders. It has the capacity to make around 8 to 9 crore tablets every month.
To meet quality and safety standards set by the FDA and FSSAI, Asston has separate areas for making pharmaceutical products and nutraceutical (health supplement) products. The company also works with five WHO-GMP certified manufacturers to ensure high-quality production.
Asston owns more than 150 registered trademarks and sells its products in different parts of the world, especially in South Africa and West Africa. The company was started in 2019 and has a team of over 50 people, guided by experienced promoters.